Diagnostic and ambulance services have grown at a projected compound annual rate of 2.7% to £11.5 billion over the five years through 2022-23. The ageing population is putting a strain on healthcare services which has ramped up public funding by the NHS for healthcare services. Still, government spending has risen at a slower rate than demand for healthcare services, stretching the budget. Growing waiting lists for NHS appointments have boosted demand for private healthcare operators. This is despite disposable income falling in 2022-23, since affordable care plans are more readily available. This industry covers health care that is not provided by hospitals, medical doctors or dentists. Operators help doctors diagnose their patients by providing specimen analysis and imaging. They also operate ambulance services and blood, sperm and organ transplant banks. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.Positive performance: The range of services outsourced to the private sector is rising, aiding profit margins
Table of Contents
ABOUT THIS INDUSTRY- Industry Definition
- Main Activities
- Similar Industries
- Additional Resources
INDUSTRY PERFORMANCE
- Executive Summary
- Key External Drivers
- Current Performance
- Industry Outlook
- Industry Life Cycle
- Supply Chain
- Products & Services
- Major Markets
- Globalisation & Trade
- Business Locations
- Market Share Concentration
- Key Success Factors
- Cost Structure Benchmarks
- Barriers to Entry
OPERATING CONDITIONS
- Capital Intensity
- Industry Data
- Annual Change
- Key Ratios
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- NHS Blood and Transplant
- London Ambulance Service NHS Trust
Methodology
LOADING...